LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.